Race against time: can ECT or ketamine stop suicidal thoughts faster?
NCT ID NCT06034821
Summary
This large study compares two fast-acting treatments—electroconvulsive therapy (ECT) and intravenous ketamine—for people experiencing severe suicidal depression. Researchers want to see which treatment works better at quickly reducing suicidal thoughts in 1,500 adults aged 18-90. The goal is to provide clear guidance for doctors and patients when immediate treatment is needed for this life-threatening condition.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE SUICIDAL DEPRESSION (ASD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Center for Addiction and Mental Health (University of Toronto)
Toronto, Ontario, M6J 1H4, Canada
-
Cleveland Clinic
Cleveland, Ohio, 44195, United States
-
Johns Hopkins University
Baltimore, Maryland, 21287, United States
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
-
McLean Hospital
Belmont, Massachusetts, 02478, United States
-
Mount Sinai School of Medicine
New York, New York, 10029, United States
-
UC San Francisco
San Francisco, California, 94143, United States
-
UTHealth Houston
Houston, Texas, 77030, United States
-
University of Pittsburgh
Pittsburgh, Pennsylvania, 15213, United States
-
University of Utah
Salt Lake City, Utah, 84132, United States
Conditions
Explore the condition pages connected to this study.